                         SEQUENCE LISTING

<110>   Immune System Key Ltd.
 
<120>  PHARMACEUTICAL COMPOSITIONS AND METHODS FOR THE TREATMENT AND 
       PREVENTION OF METASTATIC CANCER

<130>  2318215

<150>  US 61/912,156
<151>  2013-12-05

<160>  4     

<170>  PatentIn version 3.5

<210>  1
<211>  84
<212>  PRT
<213>  Homo sapiens

<400>  1

Met Met Ala Leu Arg Ser Gln Gly Leu Met Leu Pro Gln Ser Cys Pro 
1               5                   10                  15      


Gln Leu Ala Phe Leu Thr Leu Ser Ala Leu Ala Ala Val Ser Phe Ser 
            20                  25                  30          


Ala Leu His Leu Trp Leu Ser Gly Glu Pro Val Gln Ser Ser Gly Thr 
        35                  40                  45              


Lys Asp Met Arg Ser Lys Ser Asp Ser Lys Arg Val Ser Asp Lys Gln 
    50                  55                  60                  


Leu Ile Ser Lys Ala Val Trp Trp Thr Phe Phe Leu Pro Ser Thr Leu 
65                  70                  75                  80  


Trp Glu Arg Lys 
                


<210>  2
<211>  51
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  isolated synthetic peptide (fragment of T 101 peptide)

<400>  2

Leu His Leu Trp Leu Ser Gly Glu Pro Val Gln Ser Ser Gly Thr Lys 
1               5                   10                  15      


Asp Met Arg Ser Lys Ser Asp Ser Lys Arg Val Ser Asp Lys Gln Leu 
            20                  25                  30          


Ile Ser Lys Ala Val Trp Trp Thr Phe Phe Leu Pro Ser Thr Leu Trp 
        35                  40                  45              


Glu Arg Lys 
    50      


<210>  3
<211>  14
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  isolated artificial peptide (C-terminal fragment of  T101 
       peptide)

<400>  3

Trp Trp Thr Phe Phe Leu Pro Ser Thr Leu Trp Glu Arg Lys 
1               5                   10                  


<210>  4
<211>  14
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide "Nerofe"


<220>
<221>  MISC_FEATURE
<222>  (1)..(1)
<223>  Xaa is equal to D-Trp

<220>
<221>  MISC_FEATURE
<222>  (2)..(2)
<223>  Xaa is equal to D-Trp

<220>
<221>  MISC_FEATURE
<222>  (3)..(3)
<223>  Xaa is equal to D-Thr

<220>
<221>  MISC_FEATURE
<222>  (4)..(4)
<223>  Xaa is equal to D-Phe

<220>
<221>  MISC_FEATURE
<222>  (5)..(5)
<223>  Xaa is equal to D-Phe

<220>
<221>  MISC_FEATURE
<222>  (6)..(6)
<223>  Xaa is equal to D-Leu

<220>
<221>  MISC_FEATURE
<222>  (7)..(7)
<223>  Xaa is equal to D-Pro

<220>
<221>  MISC_FEATURE
<222>  (8)..(8)
<223>  Xaa is equal to D-Ser

<220>
<221>  MISC_FEATURE
<222>  (9)..(9)
<223>  Xaa is equal to D-Thr

<220>
<221>  MISC_FEATURE
<222>  (10)..(10)
<223>  Xaa is equal to D-Leu

<220>
<221>  MISC_FEATURE
<222>  (11)..(11)
<223>  Xaa is equal to D-Trp

<220>
<221>  MISC_FEATURE
<222>  (12)..(12)
<223>  Xaa is equal to D-Glu

<220>
<221>  MISC_FEATURE
<222>  (13)..(13)
<223>  Xaa is equal to D-Arg

<220>
<221>  MISC_FEATURE
<222>  (14)..(14)
<223>  Xaa is equal to D-Lys

<400>  4

Xaa Xaa Xaa Xaa Xaa Xaa Xaa Xaa Xaa Xaa Xaa Xaa Xaa Xaa 
1               5                   10                  


